Completing tuberculosis prophylaxis in jail: targeting treatment and a comparison of rifampin/pyrazinamide with isoniazid regimens

被引：0

作者：

Lambert, LA ^{[1
]}

Ijaz, K ^{[1
]}

Navin, TR ^{[1
]}

机构：

[1] Ctr Dis Control & Prevent, Div TB Eliminat, Dept Hlth & Human Serv, DTBE, Atlanta, GA 30333 USA

来源：

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE | 2005年 / 9卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：230 / 230

页数：1

共 50 条

[31] Safety of 2 months of rifampin and pyrazinamide for treatment of latent tuberculosis
Stout, JE
Engemann, JJ
Cheng, AC
Fortenberry, ER
Hamilton, CD
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (06) : 824 - 827
[32] Rifampin and pyrazinamide for treatment of latent tuberculosis infection - Reply to Cook
McElroy, PD
Ijaz, K
Navin, TR
CLINICAL INFECTIOUS DISEASES, 2006, 42 (06) : 892 - 893
[33] TYPE III HYPERSENSITIVITY REACTION TO RIPE (RIFAMPIN, ISONIAZID, PYRAZINAMIDE AND ETHAMBUTOL) THERAPY IN A PATIENT WITH TUBERCULOSIS
Draikiwicz, S.
Capitle, E.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A42 - A42
[34] SUPERVISED 6-MONTHS TREATMENT OF NEWLY DIAGNOSED PULMONARY TUBERCULOSIS USING ISONIAZID, RIFAMPIN, AND PYRAZINAMIDE WITH AND WITHOUT STREPTOMYCIN
SNIDER, DE
GRACZYK, J
BEK, E
ROGOWSKI, J
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1984, 130 (06): : 1091 - 1094
[35] Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis
Schaberg, T
Rebhan, K
Lode, H
EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (10) : 2026 - 2030
[36] LIMITED TOLERANCE OF OF OFLOXACIN AND PYRAZINAMIDE PROPHYLAXIS IN HEALTH-CARE WORKERS FOLLOWING EXPOSURE TO RIFAMPIN-ISONIAZID-STREPTOMYCIN-ETHAMBUTOL-RESISTANT TUBERCULOSIS
HORN, DL
HEWLETT, D
ALFALLA, C
PELLA, P
FRANCHINI, D
PETERSON, S
OPAL, SM
INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1995, 4 (03) : 219 - 225
[37] PYRAZINAMIDE-ISONIAZID IN LOW DOSAGE IN TREATMENT OF PULMONARY TUBERCULOSIS
ALLISON, ST
AMERICAN REVIEW OF TUBERCULOSIS AND PULMONARY DISEASES, 1956, 74 (03): : 401 - 409
[38] ISONIAZID-RESISTANT TUBERCULOSIS - A COMMUNITY OUTBREAK AND REPORT OF A RIFAMPIN PROPHYLAXIS FAILURE
LIVENGOOD, JR
SIGLER, TG
FOSTER, LR
BOBST, JG
SNIDER, DE
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 253 (19): : 2847 - 2849
[39] TREATMENT OF PULMONARY TUBERCULOSIS WITH ISONIAZID AND PYRAZINAMIDE - EXPERIENCE IN 114 CASES
SMALL, MJ
DISEASES OF THE CHEST, 1959, 36 (03): : 265 - 279
[40] The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH
Iacobino, Angelo
Giannoni, Federico
Pardini, Manuela
Piccaro, Giovanni
Fattorini, Lanfranco
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (07)

← 1 2 3 4 5 →